Encouraging rational antibiotic prescribing behaviour in primary care - prescribing practice among children aged 0-4

Maria Run Gunnlaugsdottir1, Kristjan Linnet2, Jon Steinar Jonsson2,3

  • 1Faculty of Pharmaceutical Sciences, University of Iceland, Reykjavík, Iceland.

Insights

Antibiotic prescriptions for young children decreased by 9% after implementing new guidelines. The study observed a shift in antibiotic choices, aligning with quality improvement goals in Iceland.

Area of Science:

  • Pediatrics
  • Infectious Diseases
  • Public Health

Background:

  • Antibiotic prescribing rates in Iceland are notably high compared to other Nordic countries.
  • A significant portion of antibiotic prescriptions may be inappropriate for common childhood infections.
  • Quality improvement projects are essential for optimizing antibiotic use in primary healthcare.

Purpose of the Study:

  • To evaluate the impact of a quality improvement project on antibiotic prescribing patterns in children aged 0-4 years.
  • To assess changes in the total number and type of antibiotic prescriptions before and after intervention.
  • To align antibiotic prescribing with national guidelines for prudent use in primary care.

Main Methods:

  • An observational, descriptive, retrospective quantitative study was conducted.
  • Data were collected from primary healthcare centers in the capital region of Iceland (2016-2018).
  • Prescriptions for 6,420 children aged 0-4 years were analyzed, excluding out-of-hours prescriptions.

Main Results:

  • A 9% reduction in total antibiotic prescriptions was observed between 2017-2018.
  • Amoxicillin prescriptions increased by 51.3%, while co-amoxiclav and macrolide use decreased significantly (52.3% and 40.7%, respectively).
  • Prescriptions were most common for otitis media, pneumonia, and skin infections.

Conclusions:

  • The quality improvement project successfully reduced overall antibiotic prescribing in young children.
  • A significant shift in the antibiotic profile towards recommended agents was achieved.
  • The findings support the effectiveness of guideline implementation and feedback in promoting judicious antibiotic use.
Abstract

Related Concept Videos

Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
47
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
39
Drug Dosing: Infants and Children01:29

Drug Dosing: Infants and Children

Pediatric patient dosages diverge from adults due to disparities in body surface area, total body water, and extracellular fluid per kilogram of body weight. The dosing regimen considers the variations in pharmacokinetics and pharmacology across distinct age groups, encompassing preterm newborns, infants, young children, older children, and adolescents. Calculation of pediatric patient doses is predicated on determining body surface area, which exhibits a superior correlation with the child's...
57
Pharmacokinetics in Pediatric Patients: Drug Distribution01:17

Pharmacokinetics in Pediatric Patients: Drug Distribution

Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight,...
57
Antibiotic Selection00:57

Antibiotic Selection

Overview
56.7K
Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

Pharmacokinetics in Pediatric Patients: Drug Metabolism

In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses...
44